SCHEMBL7959978

SCHEMBL7959978

O=C(O)c1ccc(CC2CCC=C2c2nc(-c3ccccc3)c(-c3ccccc3)o2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.71
PTGIR P43119 4/20 0.71
PTGER1 P34995 1/20 0.71
PTGER3 P43115 1/20 0.56
NR4A2 P43354 9/20 0.41
NR4A1 P22736 2/20 0.39
NR4A3 Q92570 2/20 0.39
RXRA P19793 3/20 0.38
RXRB P28702 3/20 0.38
RXRG P48443 3/20 0.38
FABP4 P15090 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
ABCC4 O15439 1/20 0.38
C5 P01031 1/20 0.38
LMNA P02545 1/20 0.38
CHRM2 P08172 1/20 0.38
CYP3A4 P08684 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960451 0.94 PTGER4 (0.81) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7957721 0.94 PTGER4 (0.81) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7957594 0.93 PTGIR (0.76) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7949886 0.89 PTGIR (0.89) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7958123 0.89 PTGIR (0.89) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7959285 0.87 PTGIR (0.83) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7949540 0.84 PTGER4 (0.69) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL1626140 0.83 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7960055 0.83 PTGIR (1.00) PTGER4PTGIRPTGER1PTGER3NR4A2
SCHEMBL7949617 0.83 PTGIR (0.77) PTGER4PTGIRPTGER1PTGER3NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed